Reports on the study conducted by Johns Hopkins researchers on the benefits of treating childhood asthma in accordance with guidelines issued by the National Heart, Lung & Blood Institute. Factors that worsen asthma; Comparison of treatment provided by specialists and generalists....
Asthma is a serious disease that affects about 25 million Americans and causes nearly 1.6 million emergency room visits every year. With treatment, you can live well. Without it, you might have to go to the ER often or stay at the hospital, which can affect your daily life. Tell your do...
Asthma is a serious disease that affects about 25 million Americans and causes nearly 1.6 million emergency room visits every year. With treatment, you can live well. Without it, you might have to go to the ER often or stay at the hospital, which can affect your daily life. Tell your do...
The CSACI is the largest national professional medical specialty organization in Canada representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic diseases. The CSACI was founded in 1945 to ...
This study reviewed the evidence-base for asthma treatment in children and concluded that early-life intervention is crucial to prevent asthma from evolving over the lifecourse. PubMed Google Scholar Zeiger, R. S. et al. Daily or intermittent budesonide in preschool children with recurrent ...
GINA weist unter anderem darauf hin, dass eine Asthma-Thera- pie einem kontinuierlichen Zyklus aus Beurteilung, Behandlung und Bewertung (assessment, treatment, and review) folgt. Diese Strategie minimiere Symptome und verhindere Exazerbationen. Zudem solle ein Asthma bronchiale bei Erwachsenen...
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years BACKGROUND: The greatest prevalence of asthma is in preschool children; however, the clinical utility of asthma therapy for this age group is limited by a ... B Knorr,LM ...
Owing to the heterogeneous nature of the disease, these patients usually encounter difficulties in their treatment course.3,4 Bronchial inflammation, smooth muscle spasm, and mucus production in allergic asthma are triggered by IL-4, IL-5, and IL-13, which are released by Th2 cells. IL-13 ...
† An asthma attack (exacerbation) was defined as an increase in asthma symptoms (shortness of breath, coughing, wheezing, or chest tightness), or trouble breathing for 2 or more consecutive days, requiring additional treatment. Eligible patients pay as little as $35‡ for a 30-day prescri...
Other important criteria were: severe tachypnea, clinical dyspnea, O2 saturation below 91%, and repeat visit following failure to comply with treatment. Wheezing and auscultation findings were not indications for referral to the ER, nor were parental factors. The abovementioned criteria plus normal ...